FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085174974> ?p ?o ?g. }

• W2085174974 endingPage "1610" @default.
• W2085174974 startingPage "1610" @default.
• W2085174974 abstract "Recommendations for postmenopausal hormone therapy have changed since the Women's Health Initiative indicated that estrogen was harmful for use in disease prevention; however, treatment of menopausal symptoms with low-dose estrogen remains an approved indication for use.To compare the short-term efficacy and adverse effects of 2 commonly used estrogens, conjugated equine estrogen (CEE) and 17beta-estradiol, for reducing menopausal hot flashes by systematically reviewing randomized controlled trials.MEDLINE, EMBASE, the Cochrane Database of Systematic Reviews, and Cochrane Controlled Trials Registry were searched from the database start dates to July 2003 using database-specific key words. Reference lists of published articles, experts, and pharmaceutical manufacturers were also consulted.English-language abstracts of double-blind, randomized, placebo-controlled trials and systematic evidence reviews of oral CEE and oral and transdermal 17beta-estradiol, and treatment of menopausal hot flashes and their adverse effects.Study design, population characteristics, eligibility criteria, interventions, withdrawals, adverse effects, and results for each outcome. Study quality was assessed using predefined criteria based on parameters developed with the US Preventive Services Task Force and the UK National Health Services Centre.A total of 32 trials including 4 head-to-head comparisons met inclusion criteria; 14 trials met criteria for meta-analysis. All estrogen agents significantly reduced the weekly number of hot flashes compared with placebo (CEE, 1 trial: mean change, -19.1; 95% confidence interval [CI], -33.0 to -5.1; oral 17beta-estradiol, 5 trials: pooled weighted mean difference, -16.8; 95% CI, -23.4 to -10.2; transdermal 17beta-estradiol, 6 trials: pooled weighted mean difference, -22.4; 95% CI, -35.9 to -10.4); differences between agents were not significant. Breast tenderness and atypical vaginal bleeding were the most frequently reported adverse effects among estrogen users. The influence of progestin or progesterone use, cyclic and continuous regimens, and differences in adverse effects could not be determined.Conjugated equine estrogen and 17beta-estradiol have consistent and comparable effects on treatment of menopausal hot flashes and may have similar short-term adverse effects." @default.
• W2085174974 created "2016-06-24" @default.
• W2085174974 creator A5010829414 @default.
• W2085174974 date "2004-04-07" @default.
• W2085174974 modified "2023-09-24" @default.
• W2085174974 title "Commonly Used Types of Postmenopausal Estrogen for Treatment of Hot Flashes" @default.
• W2085174974 cites W1593442063 @default.
• W2085174974 cites W162092248 @default.
• W2085174974 cites W1965348990 @default.
• W2085174974 cites W1966310725 @default.
• W2085174974 cites W1969735447 @default.
• W2085174974 cites W1972303849 @default.
• W2085174974 cites W1981922048 @default.
• W2085174974 cites W1983877611 @default.
• W2085174974 cites W1989994539 @default.
• W2085174974 cites W1993825662 @default.
• W2085174974 cites W2002305772 @default.
• W2085174974 cites W2005769596 @default.
• W2085174974 cites W200640091 @default.
• W2085174974 cites W2008362821 @default.
• W2085174974 cites W2018518729 @default.
• W2085174974 cites W2019895899 @default.
• W2085174974 cites W2023153884 @default.
• W2085174974 cites W2029453104 @default.
• W2085174974 cites W2031570803 @default.
• W2085174974 cites W2034304208 @default.
• W2085174974 cites W2039563337 @default.
• W2085174974 cites W2052594930 @default.
• W2085174974 cites W2056673914 @default.
• W2085174974 cites W2060441344 @default.
• W2085174974 cites W2060488963 @default.
• W2085174974 cites W2069123743 @default.
• W2085174974 cites W2073867415 @default.
• W2085174974 cites W2075416644 @default.
• W2085174974 cites W2075506379 @default.
• W2085174974 cites W2082571940 @default.
• W2085174974 cites W2089714738 @default.
• W2085174974 cites W2109788618 @default.
• W2085174974 cites W2124171187 @default.
• W2085174974 cites W2126066542 @default.
• W2085174974 cites W2129353515 @default.
• W2085174974 cites W2130930821 @default.
• W2085174974 cites W2159416358 @default.
• W2085174974 cites W2345890 @default.
• W2085174974 cites W2416678417 @default.
• W2085174974 cites W2417580015 @default.
• W2085174974 cites W2791877 @default.
• W2085174974 doi "https://doi.org/10.1001/jama.291.13.1610" @default.
• W2085174974 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15069049" @default.
• W2085174974 hasPublicationYear "2004" @default.
• W2085174974 type Work @default.
• W2085174974 sameAs 2085174974 @default.
• W2085174974 citedByCount "269" @default.
• W2085174974 countsByYear W20851749742012 @default.
• W2085174974 countsByYear W20851749742013 @default.
• W2085174974 countsByYear W20851749742014 @default.
• W2085174974 countsByYear W20851749742015 @default.
• W2085174974 countsByYear W20851749742016 @default.
• W2085174974 countsByYear W20851749742017 @default.
• W2085174974 countsByYear W20851749742018 @default.
• W2085174974 countsByYear W20851749742019 @default.
• W2085174974 countsByYear W20851749742020 @default.
• W2085174974 countsByYear W20851749742021 @default.
• W2085174974 countsByYear W20851749742022 @default.
• W2085174974 countsByYear W20851749742023 @default.
• W2085174974 crossrefType "journal-article" @default.
• W2085174974 hasAuthorship W2085174974A5010829414 @default.
• W2085174974 hasBestOaLocation W20851749741 @default.
• W2085174974 hasConcept C126322002 @default.
• W2085174974 hasConcept C142724271 @default.
• W2085174974 hasConcept C168563851 @default.
• W2085174974 hasConcept C17744445 @default.
• W2085174974 hasConcept C189708586 @default.
• W2085174974 hasConcept C197934379 @default.
• W2085174974 hasConcept C199539241 @default.
• W2085174974 hasConcept C204787440 @default.
• W2085174974 hasConcept C27081682 @default.
• W2085174974 hasConcept C2777164284 @default.
• W2085174974 hasConcept C2779473830 @default.
• W2085174974 hasConcept C2908647359 @default.
• W2085174974 hasConcept C44249647 @default.
• W2085174974 hasConcept C535046627 @default.
• W2085174974 hasConcept C71924100 @default.
• W2085174974 hasConcept C82789193 @default.
• W2085174974 hasConcept C95190672 @default.
• W2085174974 hasConcept C99454951 @default.
• W2085174974 hasConceptScore W2085174974C126322002 @default.
• W2085174974 hasConceptScore W2085174974C142724271 @default.
• W2085174974 hasConceptScore W2085174974C168563851 @default.
• W2085174974 hasConceptScore W2085174974C17744445 @default.
• W2085174974 hasConceptScore W2085174974C189708586 @default.
• W2085174974 hasConceptScore W2085174974C197934379 @default.
• W2085174974 hasConceptScore W2085174974C199539241 @default.
• W2085174974 hasConceptScore W2085174974C204787440 @default.
• W2085174974 hasConceptScore W2085174974C27081682 @default.
• W2085174974 hasConceptScore W2085174974C2777164284 @default.
• W2085174974 hasConceptScore W2085174974C2779473830 @default.
• W2085174974 hasConceptScore W2085174974C2908647359 @default.

• next